Dyserythropoiesis and myelodysplasia in thiamine-responsive megaloblastic anemia syndrome

Clin Case Rep. 2020 Mar 6;8(6):991-994. doi: 10.1002/ccr3.2791. eCollection 2020 Jun.

Abstract

The case of thiamine-responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow-up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances.

Keywords: deafness; diabetes mellitus; roger's syndrome; thiamine‐responsive megaloblastic anemia syndrome.

Publication types

  • Case Reports